Skip to content
Research Article Open access CC BY 3.0

Ocular Hypotensive Effect of Topical Verapamil and Diltiazem in Steroid Induced Glaucoma Model of Rabbits

Prabhakar Adake, H. S. Somashekar, C. G. Gokul, Abhishek Acharya, M. Naveen Kumar, R. Santosh

Journal of Pharmaceutical Research International · pp. 1115–1126 · Published 30 Sep 2013

10.9734/BJPR/2013/4389

Abstract

Objectives: To evaluate possible ocular hypotensive effect of 0.5% diltiazem and 0.1% verapamil eye drops on intraocular pressure in steroid induced glaucoma model of rabbits. And compare with 0.5% timolol eye drops. Methodology: Glaucoma was induced in rabbits (N=18) by bilateral topical instillation of 1% prednisolone eye drop (10 µl) twice a day for a period of 40 days. Before the induction of glaucoma, baseline intraocular pressure (IOP) in both the eyes of all rabbits was measured under sedation (i.v midazolam) by Schiotz tonometer. At the end of 40 days induced IOP was measured for all rabbits and rabbits were divided into three groups of six rabbits in each. Right eyes of group A, B and C rabbits received 0.5% diltiazem, 0.1% verapamil, and 0.5% timolol eye drops twice daily for 12 days respectively. Whereas, left eyes of all rabbits received distilled water hence represented as control. IOP was measured in all rabbits on every 4th day till 12 days of treatment period. Results: Intra-group comparisons of IOP changes were made by paired‘t’ test. And unpaired‘t’ test for inter group comparisons. One way ANOVA was used for multiple group comparisons followed by post-hoc Tukey’s test for group wise comparisons. In 0.5% diltiazem treated eyes, the mean IOP significantly reduced from 22.9±1.9 mmHg (10%) on 4th day to 16.9±1.1 mmHg(S, P<.001) on 12th day (34%). Similarly, mean IOP in 0.1% verapamil treated eyes significantly reduced from 22.7±1.3 mmHg (7%) on 4th day to 15.5±1.4 mmHg(S, P<.001) on 12th day (37%). Whereas, mean IOP significantly reduced from 22.4±1.9 mmHg (14%) on 4th day to 16.4±1.4 mmHg (S, P=.001) on 12th day (36%) in 0.5% timolol treated eyes. Conclusion: Topical 0.5% diltiazem and 0.1% verapamil significantly reduced the IOP in steroid induced glaucoma model of rabbits. However, Further research has to be carried out both in experimental and clinical subjects to reveal its efficacy and safety profile.

Diltiazem intraocular pressure timolol verapamil

References (27)

  1. 1 The Ocular Hypertension Treatment Study [DOI]
  2. 2 Ocular pharmacology
  3. 3 Ca2+ channel blockers modulate metabolism of collagens within the extracellular matrix. [DOI]
  4. 4 A Placebo-Controlled 3-Year Study of a Calcium Blocker on Visual Field and Ocular Circulation in Glaucoma with Low-Normal Pressure [DOI]
  5. 5 Becker-Shaffer's Diagnosis and Therapy of the Glaucomas [DOI]
  6. 6 Effect of nimodipine on ocular blood flow and colour contrast sensitivity in patients with normal tension glaucoma [DOI]
  7. 7 Sustained Reduction of Intraocular Pressure in Humans With the Calcium Channel Blocker Verapamil [DOI]
  8. 8 Color Doppler Ultrasound Analysis of Ocular Circulation After Topical Calcium Channel Blocker [DOI]
  9. 9 Elevation of Intraocular Pressure by Calcium Channel Blockers [DOI]
  10. 10 Effect of Calcium Channel Blockers on Intraocular Pressure [DOI]
  11. 11 The Effect of Topical Diltiazem on the Intraocular Pressure in Betamethasone-Induced Ocular Hypertensive Rabbits [DOI]
  12. 12 A long-lasting hypotensive effect of topical diltiazem on the intraocular pressure in conscious rabbits [DOI]
  13. 13 The topical application of verapamil and nifedipine lowers intraocular pressure in conscious rabbits [DOI]
  14. 14 Effect of Calcium Channel Blockers Alone and in Combination With Antiglaucoma Medications on Intraocular Pressure in the Primate Eye [DOI]
  15. 15 Topical verapamil and episcleral venous pressure11The authors have no proprietary interest in any of the drugs or devices described in this study. [DOI]
  16. 16 Papaverine and verapamil interaction with prostaglandin E2 and Δ9-tetrahydrocannabinol in the eye [DOI]
  17. 17 Nimodipine Plasma Concentration and Retinal Blood Flow in Healthy Subjects [DOI]
  18. 18 Comparative Study of Topical Application of Timolol and Verapamil in Patients With Glaucoma Within 6 Months [DOI]
  19. 19 Effect of the calcium antagonist nifedipine on intraocular pressure in normal subjects. [DOI]
  20. 20 The effect of cation ionophores on intraocular pressure.
  21. 21 ONE-DROP STUDY TO EVALUATE SAFETY AND EFFICACY OF AN OPHTHALMIC CALCIUM CHANNEL BLOCKER, VERAPAMIL, IN SUBJECTS WITH. ELEVATED INTRAOCULAR PRESSURE
  22. 22 The Influence of the Calcium Channel Blocker Verapamil on Experimental Glaucoma [DOI]
  23. 23 VERAPAMIL INCREASES FACILITY OF OUTFLOW IN THE HUMAN EYE
  24. 24 Defects in cortisol-metabolizing enzymes in primary open-angle glaucoma.
  25. 25 5 beta-Dihydrocortisol: possible mediator of the ocular hypertension in glaucoma.
  26. 26 Expectations in the treatment of retinal diseases: Neuroprotection [DOI]
  27. 27 Low-Tension Glaucoma [DOI]

Cited by 4

Development of eye drops containing antihypertensive drugs: formulation of aqueous irbesartan/γCD eye drops

Phatsawee Jansook, Chutimon Muankaew, Einar Stefánsson · Pharmaceutical Development and Technology · 2014

The effect of Calcium channel blocker in the Betamethasone-induced Glaucoma model in rabbits

Waleed K. Abdulsahib, Sattar J. Abood · Journal Of Advanced Pharmacy Education And Research · 2021

Showing 2 of 4 known citations — external sources report more than can currently be individually listed.

Related research

Article metrics

Real usage data collected on this platform.

48

Page views

0

PDF downloads

6

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.